The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
基本信息
- 批准号:10911525
- 负责人:
- 金额:$ 11.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Administrative SupplementAgeAgingBiological AssayDataEstradiolEstrogen TherapyEstroneGenitourinary systemGonadal Steroid HormonesGrantHealthHormonesImmunoassayLaboratoriesLigandsLiquid ChromatographyMeasurementMeasuresMenopausal SyndromeMenopauseMenstruationMethodsMichiganPerimenopausePhysiologicalPostmenopauseReportingSamplingSampling StudiesSerumServicesStudy of Women&aposs Health Across the NationTechnologyTestosteroneTimeUniversitiesVaginaVariantVisitWomanbiopsychosocialcohortdetection limitfollow-uphuman old age (65+)liquid chromatography mass spectrometrymiddle agetandem mass spectrometry
项目摘要
PROJECT SUMMARY
SWAN, the Study of Women's Health Across the Nation, has collected a wealth of
biopsychosocial and physiologic data on an inception cohort of 3,302 women, most of whom
have adhered to follow-up examinations spanning 25 years. Since the original aims of SWAN
were to characterize the menopausal transition in women, sex steroid measurements for
estradiol (E2) and testosterone (T) have been a crucial part of the project from the start. In the
early years of SWAN, state-of-the-art, highly sensitive, direct immunoassays (IA) for E2 and T
were developed by the University of Michigan Central Ligand Assay Satellite Services (CLASS)
Laboratories. Liquid chromatography/mass spectrometry (LC-MS/MS)-based technology has
now largely supplanted IA for hormone measurement. SWAN has adapted to this change by
performing all sex steroid assays using LC-MS/MS from Visit 15 onwards. However, all
hormone levels performed on the cohort from the baseline (Visit 0) to Visit 13 have been
performed using IA and require reconciliation to LC-MS/MS. The proportion of undetectable
samples for both E2 and T has also increased over time as the SWAN sample are now all well
past their final menses. Correlation of IA to LC-MS/MS sufficient to allow for conversion of one
method to the other for hormones is incomplete due to an inability to resolve the lower limit of
detection. In the current SWAN-Aging U19 grant, we have planned to reanalyze E2 and T using
a contemporary LC-MS/MS-based technology. We now propose to develop and measure E2
and estrone (E1) using an ultrasensitive LC-MS/MS-based assay that will measure reliably as
low as 1 pg/mL E2. This assay will be used subsequently for postmenopausal samples from
SWAN. The current administrative supplement proposes 1 new aim, Aim 1: To develop an
ultrasensitive liquid chromatography/tandem mass spectrometry (LC-MS/MS) assay for E1 and
E2 that performs with <15% intra- and inter-assay coefficients of variation (CV) at 2 pg/mL and
a LLOQ of 1 pg/mL. Accomplishment of this aim will allow us to maximize the use of SWAN
assay data moving forward, which has to date resulted in approximately 100,000 serum sex
steroid measurements in women who have traversed the menopause and are now all
postmenopausal and over the age of 70, and to determine the true circulating E2 increment that
is observed in women reporting use of topical vaginal estrogen for treatment of genitourinary
syndrome of menopause (GSM).
项目摘要
天鹅是全国妇女健康的研究,已经收集了很多
关于3,302名妇女的成立队列的生物心理社会和生理数据,其中大多数
遵守25年的后续考试。由于天鹅的最初目的
是为了表征女性的更年期过渡,性类固醇测量
从一开始,雌二醇(E2)和睾丸激素(T)一直是该项目的关键部分。在
天鹅的早期,最先进的,高度敏感的直接免疫测定(IA)
由密歇根大学中央配体测定卫星服务(类)开发
实验室。液相色谱/质谱(LC-MS/MS)的技术具有
现在,主要取代了IA的激素测量。天鹅已经适应了这种变化
从访问开始时,使用LC-MS/MS进行所有性类固醇测定。但是,一切
从基线(访问0)到访问13的同类中进行的激素水平已经
使用IA进行,并需要核对与LC-MS/MS。无法检测到的比例
E2和T的样品随着时间的流逝也有所增加,因为天鹅样品现在都很好
超越了他们的最后月经。 IA与LC-MS/MS的相关性足以允许转化一个
由于无法解析下限
检测。在当前的天鹅U19赠款中,我们计划使用E2和T进行重新分析
现代LC-MS/MS的技术。我们现在建议开发和测量E2
使用基于LC-MS/MS的超敏化测定法,将可靠地测量为
低至1 pg/ml E2。此测定将随后用于从中的绝经后样本
天鹅。当前的行政补充提出了1个新目标,目标1:开发一个
E1和
E2在2 pg/mL时进行<15%的变异(CV)内和测定间系数
1 pg/ml的LLOQ。实现这一目标将使我们能够最大化天鹅的使用
测定数据向前发展,迄今已导致大约100,000个血清性别
经过更年期的女性的类固醇测量
绝经后和70岁以上,并确定真正的循环E2增量
在报告使用局部阴道雌激素治疗泌尿生殖器的女性中观察到
更年期综合征(GSM)。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantifying physical activity across the midlife: Does consideration of perceived exertion matter?
- DOI:10.1016/j.pmedr.2022.101850
- 发表时间:2022-08
- 期刊:
- 影响因子:2.8
- 作者:Ylitalo, Kelly R.;Karvonen-Gutierrez, Carrie A.;Oh, Minsuk;Sternfeld, Barbara;Stamey, James;Gabriel, Kelley Pettee
- 通讯作者:Gabriel, Kelley Pettee
Migraine with aura.
有先兆的偏头痛。
- DOI:10.1136/bmj.a745
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Lipton,RichardB;Derby,CarolA
- 通讯作者:Derby,CarolA
Self-Reported Sleep Disturbances over the Menopausal Transition and Fracture Risk: The Study of Women's Health Across the Nation.
- DOI:10.1002/jbm4.10762
- 发表时间:2023-08
- 期刊:
- 影响因子:3.8
- 作者:Cauley, Jane A.;Kravitz, Howard M.;Ruppert, Kristine;Lian, Yinjuan;Hall, Martica J.;Harlow, Sioban D.;Finkelstein, Joel S.;Greendale, Gail
- 通讯作者:Greendale, Gail
Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
- DOI:10.1093/humrep/deac028
- 发表时间:2022-05-03
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women's Health Across the Nation (SWAN).
在全国女性健康研究 (SWAN) 中,开始服用二甲双胍对 2 型糖尿病女性骨矿物质密度的影响。
- DOI:10.1007/s00198-023-06915-3
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Solomon,DanielH;Ruppert,Kristine;Cauley,JaneA;Lian,Yinjuan;Altwies,Hallie;Shieh,Albert;Burnett-Bowie,Sherri-AnnM
- 通讯作者:Burnett-Bowie,Sherri-AnnM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Mori Brooks其他文献
ORBITA revisited: what it really means and what it does not?
重新审视 ORBITA:它的真正含义是什么,不是什么?
- DOI:
10.1093/eurheartj/ehx796 - 发表时间:
2018 - 期刊:
- 影响因子:39.3
- 作者:
B. Chaitman;Maria Mori Brooks;K. Fox;T. Lüscher - 通讯作者:
T. Lüscher
CULTURING BLASTOCYSTS TO DAY 7 OF DEVELOPMENT YIELDS DECREASED ODDS OF LIVE BIRTH FOLLOWING EUPLOID FROZEN EMBRYO TRANSFER
- DOI:
10.1016/j.fertnstert.2024.07.886 - 发表时间:
2024-10-01 - 期刊:
- 影响因子:
- 作者:
Belita Opene;Nicole M. Fischer;Alexandra A. Szczupak;Roy G. Handelsman;Julie M. Rios;Maria Mori Brooks;Jiaxuan Duan;Bernadette Paternoster;G. David Ball;Pamela B. Parker;Melissa Lombardozzi - 通讯作者:
Melissa Lombardozzi
Maria Mori Brooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Mori Brooks', 18)}}的其他基金
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10402934 - 财政年份:2019
- 资助金额:
$ 11.36万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10163253 - 财政年份:2019
- 资助金额:
$ 11.36万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
9926916 - 财政年份:2019
- 资助金额:
$ 11.36万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10642928 - 财政年份:2019
- 资助金额:
$ 11.36万 - 项目类别:
Myocardial Ischemia and Transfusion (MINT) - DCC
心肌缺血和输血 (MINT) - DCC
- 批准号:
10290738 - 财政年份:2016
- 资助金额:
$ 11.36万 - 项目类别:
Treatment and Risk Factor Determinants of Cardiovascular Outcomes in BARI 2D
BARI 2D 心血管结局的治疗和危险因素决定因素
- 批准号:
8625130 - 财政年份:2013
- 资助金额:
$ 11.36万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis
循环蛋白质组学对主动脉瓣狭窄心肌重塑的发展和逆转进行表型分析
- 批准号:
10844786 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
开发用于鉴定新世界猴生物标志物的免疫试剂
- 批准号:
10807651 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Advancing Geriatrics Infrastructure and Network Growth (AGING) Initiative
推进老年病学基础设施和网络发展 (AGING) 计划
- 批准号:
10732291 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
The impact of the aging immune system on periodontal disease
免疫系统老化对牙周病的影响
- 批准号:
10768043 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Research and Mentoring on Neurocognitive Disparities in Aging
衰老过程中神经认知差异的研究和指导
- 批准号:
10351110 - 财政年份:2022
- 资助金额:
$ 11.36万 - 项目类别: